Table 2.
Parameter | Univariable analysis |
Multiple regression analysis |
|||
---|---|---|---|---|---|
Pearson r | P-value | Estimatea) | Standard error | P-value | |
All patients (n=982) | |||||
Age (year) | -0.349 | <0.001 | -0.001 | 0.000 | <0.001 |
Sexa) | 0.074 | 0.021 | 0.004 | 0.005 | 0.008 |
BMI (kg/m2) | 0.513 | <0.001 | 0.002 | 0.001 | 0.020 |
SCD (mm) | 0.461 | <0.001 | 0.004 | 0.001 | <0.001 |
MR elastography | -0.054 | 0.091 | 0.008 | 0.003 | 0.004 |
MRI-derived PDFF | 0.731 | <0.001 | 0.078 | 0.003 | <0.001 |
MR elastography×MRI-derived PDFF | -0.186 | <0.001 | 0.009 | 0.004 | 0.013 |
Patients without hepatic steatosis (grade S0, n=344) | |||||
Age (year) | -0.039 | 0.467 | 0.000 | 0.000 | 0.480 |
Sexa) | -0.015 | 0.788 | -0.013 | 0.008 | 0.100 |
BMI (kg/m2) | 0.240 | <0.001 | 0.000 | 0.001 | 0.751 |
SCD (mm) | 0.361 | <0.001 | 0.006 | 0.001 | <0.001 |
MR elastography | 0.173 | 0.001 | 0.032 | 0.017 | 0.037 |
MRI-derived PDFF | 0.084 | 0.122 | 0.061 | 0.021 | <0.001 |
MR elastography×MRI-derived PDFF | -0.158 | 0.003 | 0.023 | 0.019 | 0.229 |
Patients with hepatic steatosis (grades S1-S3, n=638) | |||||
Age (year) | -0.341 | <0.001 | -0.001 | 0.000 | 0.002 |
Sexa) | 0.057 | 0.154 | 0.006 | 0.006 | 0.317 |
BMI (kg/m2) | 0.331 | <0.001 | 0.002 | 0.001 | 0.094 |
SCD (mm) | 0.285 | <0.001 | 0.002 | 0.001 | 0.004 |
MR elastography | -0.088 | 0.034 | 0.002 | 0.003 | 0.482 |
MRI-derived PDFF | 0.604 | <0.001 | 0.061 | 0.001 | <0.001 |
MR elastography×MRI-derived PDFF | 0.001 | 0.227 | 0.014 | 0.005 | 0.007 |
Estimated value of coefficients.
Steatosis grade: S0, MRI-PDFF <5.2%; S1, 5.2≤MRI-PDFF<11.3%; S2, 11.3≤MRI-PDFF<17.1%; and S3, MRI-PDFF ≥17.1% [12].
USAP, ultrasound attenuation parameter; BMI, body mass index; SCD, skin-capsule distance; MR, magnetic resonance; MRI, magnetic resonance imaging; PDFF, proton density fat fraction.
Female=0, male=1.